Suppr超能文献

地高辛与西咪替丁:药物相互作用可能性的研究。

Digoxin and cimetidine: investigation of the potential for a drug interaction.

作者信息

Crome P, Curl B, Holt D, Volans G N, Bennett P N, Cole D S

出版信息

Hum Toxicol. 1985 Jul;4(4):391-9. doi: 10.1177/096032718500400405.

Abstract

The potential for a pharmacokinetic interaction between digoxin and cimetidine was investigated in a series of studies. In a single-dose cross-over study in healthy volunteer subjects cimetidine increased the area under the plasma digoxin concentration curve and the peak plasma digoxin concentration. In a repeated-dose study in healthy volunteer subjects taking digoxin 0.25 mg daily, co-administration of cimetidine resulted in an average increase in plasma digoxin concentration of 0.15 ng/ml. In a repeated-dose study in healthy volunteer subjects taking digoxin 0.5 mg daily, co-administration of cimetidine resulted in an average increase in plasma digoxin concentration of 0.19 ng/ml. In a repeated-dose study in patients receiving long-term digoxin therapy for atrial fibrillation co-administration of cimetidine had no significant effect on plasma digoxin concentrations. We have shown that co-administration of cimetidine and digoxin in volunteer subjects causes a statistically significant but small increase in plasma digoxin concentration but no such increase was found in patients. We conclude that it is doubtful that this interaction is of any clinical significance.

摘要

在一系列研究中,对洋地黄毒苷和西咪替丁之间的药代动力学相互作用潜力进行了研究。在一项针对健康志愿者的单剂量交叉研究中,西咪替丁增加了血浆洋地黄毒苷浓度曲线下面积以及血浆洋地黄毒苷峰值浓度。在一项针对每日服用0.25毫克洋地黄毒苷的健康志愿者的重复剂量研究中,西咪替丁的共同给药导致血浆洋地黄毒苷浓度平均增加0.15纳克/毫升。在一项针对每日服用0.5毫克洋地黄毒苷的健康志愿者的重复剂量研究中,西咪替丁的共同给药导致血浆洋地黄毒苷浓度平均增加0.19纳克/毫升。在一项针对接受长期洋地黄毒苷治疗心房颤动的患者的重复剂量研究中,西咪替丁的共同给药对血浆洋地黄毒苷浓度没有显著影响。我们已经表明,在志愿者中,西咪替丁和洋地黄毒苷的共同给药会导致血浆洋地黄毒苷浓度出现统计学上显著但较小的增加,但在患者中未发现这种增加。我们得出结论,这种相互作用是否具有任何临床意义值得怀疑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验